To help raise both money and awareness for women’s cancers, Saks Fifth Avenue Bal Harbour will partner with The Mount Sinai Comprehensive Cancer Center to host the 2012 Key To The Cure, a charity shopping weekend taking place October 18 through October 21.
To launch this year’s event, Saks Fifth Avenue Bal Harbour will host a Key To The Cure kick-off celebration on Wednesday, October 17, at 7pm, featuring hors d’oeuvres, live entertainment and, of course, shopping.
Actress Penelope Cruz has been named the 2012 Entertainment Industry Foundation’s Women’s Cancer Research Fund ambassador for Saks Fifth Avenue’s 2012 KEY TO THE CURE campaign. In support of this program, Ms. Cruz will appear in a national public service announcement (PSA) wearing the Caroline Herrera limited-edition T-shirt. The Key To The Cure PSA will appear in major fashion and lifestyle magazines in September and October.
The Key to the Cure Kickoff Party will have delectable samplings provided by Acme Bakery & Coffee, Azul, Bongos Cuban Café, , City Hall, The Restaurant, Cookies by Shar, DeliverLean, Egg & Dart, Epicure Gourmet Market & Café, Essensia, Gotham Steak at the Fountainebleau, J & G Grill, Makoto, Mister Collins, Morton’s the Steakhouse, Paulina’s Pops, Smartwater, Spartico, STK, The Federal Food, Drink & Provisions, The Green House Organic Food Restaurant, Timo, We Take the Cake, and Wynwood Kitchen & Bar. Cocktails will be generously provided by Southern Wine & Spirits, and refreshments by Smart Water and Coca Cola. The Nailbar in Midtown Miami will be offering polish changes with the latest nails colors from Dior.
Admission to the kick-off party is $25 with 100% of admission proceeds going to The Mount Sinai Comprehensive Cancer Center. Admission may be reserved online by going to: www.msmcfoundation.org/Key
For additional information or to reserve your admission by phone, call the Mount Sinai Medical Center Foundation Offices at 305.674-2777.
Saks will also offer a limited-edition Key To The Cure T-shirt designed by Carolina Herrera, available beginning Friday, October 1 and retailing for $35 in Saks stores, Saks Fifth Avenue OFF 5TH stores and on saks.com. 100% of the purchase price of each T-shirt sold at Saks Bal Harbour will be donated to The Mount Sinai Comprehensive Cancer Center.
ABOUT KEY TO THE CURE
Saks Fifth Avenue initiated its charity shopping weekend in 1999. Since then, the company has donated $31 million to women’s cancer research and treatment organizations throughout the United States. Organizations benefiting from these funds include: The Breast Cancer Research Foundation; EIF’s Women’s Cancer Research Fund; Cleveland Clinic; Boston’s Dana-Farber Cancer Institute; Nevada Cancer Institute and many others.
ABOUT SAKS FIFTH AVENUE
Saks Fifth Avenue, one of the world’s preeminent specialty retailers, is renowned for its superlative American and international designer collections, its expertly edited assortment of handbags, shoes, jewellery, cosmetics and gifts, and the firstrate fashion expertise and exemplary client service of its Associates. Today, Saks operates 45 full-line stores in 21 states, 2 licensed stores in the Middle East and 2 licensed stores in Mexico City, 61 Saks Fifth Avenue OFF 5TH stores and saks.com, the company’s online store.
ABOUT THE MOUNT SINAI COMPREHENSIVE CANCER CENTER
The Mount Sinai Comprehensive Cancer Center is a nationally recognized, awardwinning facility that utilizes a collaborative, multidisciplinary approach to diagnosing and treating cancer. Mount Sinai is the only hospital in Florida, and one of only 23 in the U.S., to receive its third consecutive Outstanding Achievement Award from the American College of Surgeons Commission on Cancer (CoC). In addition, Mount Sinai’s radiation oncology program was the first in South Florida to earn accreditation from the American College of Radiology and American Society of Radiology and Oncology. As South Florida’s only National Cancer Institutefunded adult Community Clinical Oncology Program (CCOP), Mount Sinai takes part in clinical trials that give patients access to pioneering new cancer treatment options before they become available to the general public.
